Skip to main content
SpringerLink
Log in

Effect of Xymedon and Mexidol in Combination with Antineoplastic Drugs on Spermatogenesis Indicators and Functional State of Spermatozoa in Rats with Walker-256 Carcinoma

  • PHARMACOLOGY AND TOXICOLOGY
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

We compared the effect of Xymedon (100 mg/kg), Mexidol (50 mg/kg), and their combination on spermatogenesis indicators and functional state of spermatozoa in rats with Walker-256 carcinoma treated with doxorubicin (4 mg/kg) and cyclophosphamide (45 mg/kg) (once intraperitoneally on day 11 after tumor cells transplantation). Xymedon and Mexidol were injected intramuscularly for 10 days starting from day 11 of the experiment. The studied parameters were evaluated on experimental days 14 and 21. We have established that gonadoprotective effect of Xymedon developed gradually and persisted longer than that of Mexidol. It manifested in an increase in the number of epithelial spermatogenesis cells (spermatogonia by 3.2 times, early spermatids by 2.2 times, late spermatids by 2.9 times, and Leydig cells by 4 times) in the testes and also the proportion of viable progressively and non-progressively motile epididymal spermatozoa (by 2 times). The combination of Xymedon and Mexidol stimulated spermatogenesis (with restoration of the initial level of spermatocytes, an increase in the number of early spermatids by 65.5 and 99% in comparison with Xymedon alone and Mexidol alone, respectively) and increased the number of viable epididymal spermatozoa more effectively than Xymedon and Mexidol alone by 54 and 60%, respectively.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bragina YY. Spermiologic examination protocol. Androl. Genit. Khir. 2014;15(1):15-24. https://doi.org/10.17650/2070-9781-2014-1-15-24

    Article  Google Scholar 

  2. Voronina TA, Seredenin SB. Nootropes (cognition enhancers) and neuroprotectors. Eksp. Klin. Farmakol. 2007;70(4):44-58. Russian.

    CAS  Google Scholar 

  3. Vyshinskaya EA, Bespalov VG, Vasilyeva IN, Semenov AL, Stukov AN, Belyaeva OA, Kireeva GS, Maidin MA, Gershfeld ED, Belyaev AM. Advantages of intraperitoneal chemotherapy in treatment of ovarian cancer peritoneal carcinomatosis. Zh. Akush. Zhen. Bol. 2014;63(5):38-45. Russian.

    Article  Google Scholar 

  4. Grek OR, Mishenina SV, Pupyshev AB. Protective effect of enterosgel on rat liver lysosomes during cytostatic treatment. Bull. Exp. Biol. Med. 2002;134(4):355-358.

    Article  CAS  Google Scholar 

  5. Ivanov YuV. Cytological criteria of the state of spermatogenesis in toxicological and hygienic studies Gig. San. 1986;(4):52-55. Russian.

    Google Scholar 

  6. Kaplieva IV, Bordyushkov YN, Frantsiyants EM, Trepitaki LK, Petrusenko NA, Gorina II. Life expectancy and growth dynamics of tumors induced with 3,4-benzpyrene in rats under experimental autosplenochemotherapy. Fundament. Issled. 2014;(7-3):513-516. Russian.

  7. Kidun KA, Ugolnik TS. Mitochondrial dysfunction of spermatozoa in the pathogenesis of pathosperm cells in oxidative stress (literature review). Probl. Zdorov’ya Ekol. 2013;(2):20-24. Russian.

    Google Scholar 

  8. Lutfullin МН, Garipov ТV, Shabalina ЕV. Evaluation of acute toxicity and cumulative effects of Xymedon hydrochloride. Ross. Parazitol. Zh. 2008;(2):80-83. Russian.

    Google Scholar 

  9. Masyagin VA, Siprov AV, Volkova ND, Kuznetsova VA, Shmyreva NV, Makarova MYu, Vashurkina IM. Comparative assessment of pyrimidine and 3-hydroxypyridine derivatives hematoprotective efficiency at the antitumor chemotherapy in experiment. Sovremen. Probl. Nauki Obrazovaniya. 2015;(3):190. Russian.

    Google Scholar 

  10. Siprov AV, Kostina YuA. Cardioprotective efficiency study of combination of pyrimidine and 3-hydroxypyridine derivatives in experimental antitumor chemotherapy. Saratov. Nauch.-Med. Zh. 2014;10(2):257-261. Russian.

    Google Scholar 

  11. Manual on Experimental (Preclinical) Study of New Pharmacological Substances, Khabriev RU, ed. Moscow, 2005. Russian.

  12. Chiba K, Fujisawa M. Fertility preservation in men with cancer. Reprod. Med. Biol. 2014;13(4):177-184. https://doi.org/10.1007/s12522-014-0180-6

    Article  PubMed  PubMed Central  Google Scholar 

  13. Okada K, Fujisawa M. Recovery of spermatogenesis following cancer treatment with cytotoxic chemotherapy and radiotherapy. World J. Mens Health. 2019;37(2):166-174. https://doi.org/10.5534/wjmh.180043

    Article  PubMed  Google Scholar 

  14. Rezvanfar M, Sadrkhanlou R, Ahmadi A, Shojaei-Sadee H, Rezvanfar M, Mohammadirad A, Salehnia A, Abdollahi M. Protection of CP-induced toxicity in reproductive tract histology, sperm characteristics and DNA damage by an herbal source; evidence for role of free-radical toxic stress. Hum. Exp. Toxicol. 2008;27(12):901-910. https://doi.org/10.1177/0960327108102046

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. N. P. Ogarev National Research Mordovia State University, Saransk, Russia

    A. V. Siprov, M. V. Siprova, V. I. Inchina, N. D. Volkova & V. A. Kuznetsova

Authors
  1. A. V. Siprov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. V. Siprova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V. I. Inchina
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N. D. Volkova
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. V. A. Kuznetsova
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. V. Siprov.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 171, No. 4, pp. 441-447, April, 2021

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Siprov, A.V., Siprova, M.V., Inchina, V.I. et al. Effect of Xymedon and Mexidol in Combination with Antineoplastic Drugs on Spermatogenesis Indicators and Functional State of Spermatozoa in Rats with Walker-256 Carcinoma. Bull Exp Biol Med 171, 435–440 (2021). https://doi.org/10.1007/s10517-021-05244-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-021-05244-x

Key Words

Search

Navigation